Multicystic Interstitial Lung Disease Due to a Novel Biallelic C‐C Chemokine Receptor Type 2 Variant
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.71135 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Moritz Herkner und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Hauptthemen laut MEDLINE: Receptors, CCR2, Lung Diseases, Interstitial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: M. S. is participant of the BIH-Charité Clinician Scientist Program funded by the Charité-Universitätsmedizin Berlin and the BIH. M. S. was supported by the Ge….
Abstract (Originalsprache)
Objective
We are presenting two individuals with biallelic C‐C chemokine receptor type 2 (CCR2) deficiency carrying the novel c.644C>T p.L215P variant, who presented with chronic respiratory symptoms during infancy and developed multiple diffuse cystic lesions during childhood.
Methods
The patients were diagnosed by means of whole exome sequencing and functional validation of the variant was performed in primary patient cells.
Results
While size and extent of the cysts were stable over years, progressive lung function decline was noted in adolescence and adulthood respectively. The CCR2 p.L215P variant was found to be loss‐of‐expression and patient monocytes displayed a migration defect upon stimulation with the CCR2 ligand C‐C motif ligand 2 (CCL2).
Conclusion
With a follow‐up of up to 25 years, this report expands our understanding of lung disease in CCR2 deficiency and offers another monogenic cause of cystic lung disease. Early genetic diagnosis of affected individuals might allow potentially curative treatment by haematopoietic stem cell transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
- Department of Pediatric Respiratory Medicine, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- German Center for Lung Research (DZL) Associated Partner Site, Berlin, Germany.
- Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
- Institute of Pathology, University of Würzburg, Würzburg, Germany.
- Department of Pediatrics, Division of Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
ORCID-Profile: Simon Y Graeber, Nagehan Emiralioglu, Mirjam Stahl, Matthias Griese, Florian Gothe
Förderung
- M. S. is participant of the BIH-Charité Clinician Scientist Program funded by the Charité-Universitätsmedizin Berlin and the BIH. M. S. was supported by the Ge…
Zitieren
APA
Herkner, M., Rapp, C., Graeber, S. Y., Marx, C., Rambuscheck, C., Reu-Hofer, S., Emiralioglu, N., Kiper, N., Gilea, A. I., Notaroberto, I., Baruffini, E., Temmesfeld-Wollbrück, B., Klein, C., Wen, H., Stahl, M., Griese, M., & Gothe, F. (2025). Multicystic Interstitial Lung Disease Due to a Novel Biallelic C‐C Chemokine Receptor Type 2 Variant. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71135
Vancouver
Herkner M, Rapp C, Graeber SY, Marx C, Rambuscheck C, Reu-Hofer S, et al. Multicystic Interstitial Lung Disease Due to a Novel Biallelic C‐C Chemokine Receptor Type 2 Variant. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71135
BibTeX
@article{Herkner2025,
author = {Herkner, Moritz and Rapp, Christina and Graeber, Simon Y and Marx, Charlotte and Rambuscheck, Carlotta and Reu-Hofer, Simone and Emiralioglu, Nagehan and Kiper, Nural and Gilea, Alexandru I and Notaroberto, Ilenia and Baruffini, Enrico and Temmesfeld-Wollbrück, Bettina and Klein, Christoph and Wen, Han and Stahl, Mirjam and Griese, Matthias and Gothe, Florian},
title = {Multicystic Interstitial Lung Disease Due to a Novel Biallelic C‐C Chemokine Receptor Type 2 Variant},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.71135}
}
EUVIMED